Validation research about operations of eyelid-absorbed H2 percutaneously on the eyes, the face and the central nerves - Validation research about operations of eyelid-absorbed H2 percutaneously on the eyes, the face and the central nerves

CPCC Company Limited0 个研究点目标入组 24 人开始时间: 2021年12月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects falling into the habit of smoking. (2) Subjects with the condition of being over-sensitiveness to cold, even during the summer season. (3) Subjects taking steadily in the medicine and/or the health-specific/functional/health foods, which might affect their blood flow improvement. (4) Subjects with some kind of eye disease in and around their eyes/eyelids. (5) Pregnant, possibly pregnant, or lactating women. (6) Subjects having previous/present medical history of serious diseases in heart, liver, kidney, and/or digestive organs. (7) Subjects with some kind of skin symptom, disease or disorder, just like atopic dermatitis. (8) Subjects who have undergone some kind of surgical treatment for the measurement region, within the last six months into this trial. (9) Subjects with high blood pressure-- a maximal blood pressure of not less than 160 mmHg, a minimal blood one of not less than 100 mmHg--, and so on. (10) Subjects who realized that the subjects themselves must be in a state of menopausal disorder. (11) Subjects who are now under the other clinical tests with some kind of medicine/food, or took part in those within four weeks before this trial, or are planning to participate in those after giving informed consent to take part in this trial. (12) Others who have been determined as ineligible for participation, judging from the investigator's opinions.

发起方

CPCC Company Limited